LEADER 01433nam1-2200421---450- 001 990003194530203316 005 20090210111405.0 035 $a000319453 035 $aUSA01000319453 035 $a(ALEPH)000319453USA01 035 $a000319453 100 $a20090210d2007----km-y0itay50------ba 101 $aeng 102 $aUS 105 $a||||||||001yy 200 1 $aTarget discovery and validation reviews and protocols$fedited by Mouldy Sioud 210 $aTotowa$cHumana press$d2007 215 $a2 v.$d23 cm 225 2 $aMethods in molecular biology$v360-361 410 0$12001$aMethods in molecular biology$v360-361 454 1$12001 461 1$1001-------$12001 463 \1$1001990003194540203316$12001 $a<> Emerging strategies for targets and biomarker discovery 463 \1$1001990003195830203316$12001 $a<> Emerging molecular targets and treatment options 606 0 $aTumori$xTerapia$2BNCF 676 $a616.99 700 1$aSIOUD,$bMouldy$0603158 801 0$aIT$bsalbc$gISBD 912 $a990003194530203316 951 $a616.99 EME$c616.99 959 $aBK 969 $aFAR 979 $aFIORELLA$b90$c20090210$lUSA01$h1049 979 $aFIORELLA$b90$c20090210$lUSA01$h1051 979 $aFIORELLA$b90$c20090210$lUSA01$h1057 979 $aFIORELLA$b90$c20090210$lUSA01$h1114 996 $aTarget discovery and validation reviews and protocols$91016144 997 $aUNISA LEADER 01148nam0-22003491i-450- 001 990004451840403321 005 20160928090403.0 035 $a000445184 035 $aFED01000445184 035 $a(Aleph)000445184FED01 035 $a000445184 100 $a19990604g19049999km-y0itay50------ba 101 0 $afre 105 $ay-------001yy 200 1 $aHistoire des livres du nouveau testament$fE. Jacquier 210 $aParis$cV. Lecoffre$d1904- 215 $a4 v.$d20 cm 225 1 $aBibliothèque de l'enseignement de l'histoire ecclèsiastique 327 0 $a1.: 4. éd. - 1904$a2.: 2. éd. - 1905$a3.: 2. éd. - 1908$a4.: 2. éd. - 1905 610 0 $aBibbia$aNuovo testamento 676 $a225 700 1$aJacquier,$bEugène-Jacques$f<1847-1932> 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990004451840403321 952 $a200/3 0070 (1)$bBibl. 5981a$fFLFBC 952 $a200/3 0070 (2)$bBibl. 5981b$fFLFBC 952 $a200/3 0070 (3)$bBibl. 5981c$fFLFBC 952 $a200/3 0070 (4)$bBibl. 5981d$fFLFBC 959 $aFLFBC 996 $aHistoire des livres du nouveau testament$9544551 997 $aUNINA